Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Christow, A.
Right arrow Articles by Gemzell-Danielsson, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christow, A.
Right arrow Articles by Gemzell-Danielsson, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 8, No. 4, 333-340, April 2002
© 2002 European Society of Human Reproduction and Embryology


Uterine physiology

Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube

A. Christow, X. Sun and K. Gemzell-Danielsson,1

Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden

It is likely that mifepristone or levonorgestrel in the future will find extended use for contraceptive purposes. It is therefore essential to characterize the modes of action of these compounds. To assess the effect on the human Fallopian tube, 24 women with regular menstrual cycles and proven fertility, admitted to the hospital for voluntary sterilization by laparoscopic technique, were randomly allocated to a control or one of two treatment groups. Treatments were given with either a single dose of 200 mg mifepristone or 0.75 mg levonorgestrel in two doses 12 h apart, on day LH+2. Surgery was performed on day LH+4 to LH+6. Steroid receptor expression was analysed by immunohistochemistry, Western blot and RT–PCR. In the controls, there was a higher concentration of progesterone receptors in the stromal cells in the isthmic region than in those in the ampullar region. Treatment with mifepristone increased the progesterone receptor concentration in epithelial and stromal cells and increased the estrogen receptor concentration in epithelial cells. No effect on steroid receptor concentration was found following levonorgestrel. The contraceptive effect of post-ovulatory mifepristone has previously been considered to be dependent on an effect on the endometrium. However an effect on the Fallopian tube could contribute to alter the peri-implantation milieu influencing fertilization and embryo development.

emergency contraception/Fallopian tube/levonorgestrel/mifepristone/steroid receptors

1 To whom correspondence should be addressed. E-mail: kristina.gemzell{at}kbh.ki.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
K. Wanggren, A. Stavreus-Evers, C. Olsson, E. Andersson, and K. Gemzell-Danielsson
Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens
Hum. Reprod., October 1, 2008; 23(10): 2359 - 2368.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Wanggren, P.G. Lalitkumar, F. Hambiliki, B. Stabi, K. Gemzell-Danielsson, and A. Stavreus-Evers
Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo
Mol. Hum. Reprod., June 1, 2007; 13(6): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Wanggren, P.G. Lalitkumar, A. Stavreus-Evers, B. Stabi, and K. Gemzell-Danielsson
Prostaglandin E2 and F2{alpha} receptors in the human Fallopian tube before and after mifepristone treatment
Mol. Hum. Reprod., September 1, 2006; 12(9): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Ulziibat, K. Ejima, Y. Shibata, Y. Hishikawa, M. Kitajima, A. Fujishita, T. Ishimaru, and T. Koji
Identification of estrogen receptor beta-positive intraepithelial lymphocytes and their possible roles in normal and tubal pregnancy oviducts
Hum. Reprod., September 1, 2006; 21(9): 2281 - 2289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Shao, B. Weijdegard, K. Ljungstrom, A. Friberg, C. Zhu, X. Wang, Y. Zhu, J. Fernandez-Rodriguez, E. Egecioglu, E. Rung, et al.
Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E59 - E72.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
H.Z. Li, X. Sun, A. Stavreus-Evers, and K. Gemzell-Danielsson
Effect of mifepristone on the expression of cytokines in the human Fallopian tube
Mol. Hum. Reprod., July 1, 2004; 10(7): 489 - 493.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Gemzell-Danielsson and L. Marions
Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception
Hum. Reprod. Update, July 1, 2004; 10(4): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
X. Qiu, X. Sun, A. Christow, B. Stabi, and K. Gemzell-Danielsson
The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium
Mol. Hum. Reprod., November 1, 2002; 8(11): 998 - 1004.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.